All Relations between Depression and cannabis

Publication Sentence Publish Date Extraction Date Species
Jessie B Lydiard, Herry Patel, Yoni Strugatsky, Wesley K Thompson, William E Pelham, Sandra A Brow. Prospective associations between cannabis use and depressive symptoms across adolescence and early adulthood. Psychiatry research. vol 325. 2023-05-05. PMID:37146464. overall, the relationship between cannabis use and depression appears to be complex and not unidirectional. 2023-05-05 2023-08-14 human
Kat Petrilli, Lindsey Hines, Sally Adams, Celia J Morgan, H Valerie Curran, Tom P Freema. High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence. Addictive behaviors. vol 144. 2023-04-30. PMID:37121087. we hypothesised that users of high potency cannabis would have higher levels of (a) anxiety, (b) depression and (c) psychosis-like symptoms (d) cannabis dependence than users of lower potency cannabis. 2023-04-30 2023-08-14 Not clear
H Clarke, M Fitzcharle. The evolving culture of medical cannabis in Canada for the management of chronic pain. Frontiers in pharmacology. vol 14. 2023-04-24. PMID:37089954. pain relief, sleep promotion and alleviation of distress, depression and anxiety are the most common reasons for cannabis use. 2023-04-24 2023-08-14 Not clear
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freema. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry. vol 13. issue 1. 2023-04-21. PMID:37085531. one potential mechanism of cbd is increasing levels of anandamide, which has been implicated in psychiatric disorders including depression and cannabis use disorder. 2023-04-21 2023-08-14 human
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freema. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry. vol 13. issue 1. 2023-04-21. PMID:37085531. we also investigated whether changes in plasma anandamide levels were associated with clinical outcomes relevant for cannabis use disorder (cannabis use, withdrawal, anxiety, depression). 2023-04-21 2023-08-14 human
Simon Erridge, Sajed Mangoo, Mikael H Sodergre. Letter to the editor: reflections on the future of medical cannabis research for depression. Expert review of neurotherapeutics. 2023-04-20. PMID:37078172. letter to the editor: reflections on the future of medical cannabis research for depression. 2023-04-20 2023-08-14 Not clear
Vania Modesto-Lowe, Roberto León-Barriera, Lakshit Jai. Cross-national reflections on medicinal cannabis and depression. Expert review of neurotherapeutics. 2023-04-17. PMID:37068050. cross-national reflections on medicinal cannabis and depression. 2023-04-17 2023-08-14 Not clear
Matthias Hans Belau, Christian Wiessner, Heiko Becher, Ursula von Rüden, Peer Brike. Frequent Cannabis Use Moderates the Relationship Between Sexual Dysfunction and Depression Among Female German Adults. The journal of sexual medicine. vol 19. issue 6. 2023-04-14. PMID:37057580. frequent cannabis use moderates the relationship between sexual dysfunction and depression among female german adults. 2023-04-14 2023-08-14 Not clear
Bara S Bataineh, Anna V Wilkinson, Aslesha Sumbe, Stephanie L Clendennen, Baojiang Chen, Sarah E Messiah, Melissa B Harrel. The Association Between Tobacco and Cannabis Use and the Age of Onset of Depression and Anxiety Symptoms Among Adolescents and Young Adults. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2023-04-12. PMID:37042355. the association between tobacco and cannabis use and the age of onset of depression and anxiety symptoms among adolescents and young adults. 2023-04-12 2023-08-14 Not clear
C E Okechukwu, D Robertson, G La Torre, M Ogenchu. Lifestyle behaviors among Canadian nurses working night shifts in the COVID-19 era: a pilot study. La Clinica terapeutica. vol 174. issue 2. 2023-03-15. PMID:36920133. the objectives of this study were to determine the lifestyle behaviors (prevalence of nicotine, caffeine, cannabis, sleep-promoting medication, and alcohol use) and the association between job stress, sleep quality, anxiety, and depression among registered nurses working night shifts in the canadian province of saskatchewan in the covid-19 era. 2023-03-15 2023-08-14 Not clear
Jonathon K Lisano, Jacob Kisiolek, Victoria Flores, Peter Smoak, Nicholas A Pullen, Laura K Stewar. Chronic Cannabis Use is Associated with Altered Monocyte Phenotype, Immune Response, and Depression in Physically Active Individuals. Canadian journal of physiology and pharmacology. 2023-03-03. PMID:36867857. chronic cannabis use is associated with altered monocyte phenotype, immune response, and depression in physically active individuals. 2023-03-03 2023-08-14 Not clear
Robert K Heaton, Ronald J Ellis, Bin Tang, Christina M Marra, Leah H Rubin, David B Clifford, J Allen McCutchan, Benjamin B Gelman, Susan Morgello, Donald R Franklin, Scott L Letendr. Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study. Brain : a journal of neurology. vol 146. issue 3. 2023-03-03. PMID:36477867. neurocognitive decline was unrelated to hiv disease or treatment characteristics but was significantly predicted by the presence of comorbid conditions, specifically diabetes, hypertension, chronic pulmonary disease, frailty, neuropathic pain, depression and lifetime history of cannabis use disorder. 2023-03-03 2023-11-08 human
Elizabeth Charron, Ziji Yu, Brad Lundahl, John Silipigni, Akiko Okifuji, Adam J Gordon, Jacob D Baylis, Ashley White, Kristi Carlston, Walitta Abdullah, Benjamin Haaland, Elizabeth E Krans, Marcela C Smid, Gerald Cochra. Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorder. Addictive behaviors reports. vol 17. 2023-02-27. PMID:36844693. group a compared with group b included more members with: a history of overdose (72 % vs 50 %); anxiety (85 % vs 25 %); ≥moderate pain (76 % vs 22 %); ≥moderate depression (75 % vs 36 %); ≥moderate drug use severity (94 % vs 78 %); and, more days of cannabis (mean: 6.2 vs 2.3 days), stimulant (mean: 4.5 vs 1.3 days), and injection heroin (mean: 1.3 vs 0 days) use in the past 30 days ( 2023-02-27 2023-08-14 human
Giulia De Feo, Amy A Case, Gregory B Crawford, David Hui, Josephine To, Andrea Sbrana, Bryony Alderman, Sandip Mukhopadhyay, Carole Bouleuc, Koji Amano, Kimberson Tanco, Jessica Garsed, Mellar Davi. Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. vol 31. issue 3. 2023-02-22. PMID:36809575. multinational association of supportive care in cancer (mascc) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. 2023-02-22 2023-08-14 Not clear
Sarah M Lehman, Erin L Thompson, Ileana Pacheco-Colón, Samuel W Hawes, Ashley R Adams, Karen Granja, William J Pulido, Raul Gonzale. Cannabis use and episodic memory performance among adolescents: Moderating effects of depression symptoms and sex. Journal of the International Neuropsychological Society : JINS. 2023-02-13. PMID:36775907. cannabis use and episodic memory performance among adolescents: moderating effects of depression symptoms and sex. 2023-02-13 2023-08-14 Not clear
Sarah M Lehman, Erin L Thompson, Ileana Pacheco-Colón, Samuel W Hawes, Ashley R Adams, Karen Granja, William J Pulido, Raul Gonzale. Cannabis use and episodic memory performance among adolescents: Moderating effects of depression symptoms and sex. Journal of the International Neuropsychological Society : JINS. 2023-02-13. PMID:36775907. the current study addresses this by examining interactions between depression symptoms and sex on the association between cannabis use and episodic memory in a large sample of adolescents. 2023-02-13 2023-08-14 Not clear
Uri Bright, Irit Akira. Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression. International journal of molecular sciences. vol 24. issue 3. 2023-02-11. PMID:36768376. cannabidiol modulates alterations in pfc micrornas in a rat model of depression. 2023-02-11 2023-08-14 rat
T Srinivasa Reddy, Roby Zomer, Nitin Mantr. Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids. Phytotherapy research : PTR. 2023-02-07. PMID:36748949. medical cannabis has received significant interest in recent years due to its promising benefits in the management of pain, anxiety, depression and neurological and movement disorders. 2023-02-07 2023-08-14 Not clear
Jordan P Davis, Eric R Pedersen, Joan S Tucker, John Prindle, Michael S Dunbar, Anthony Rodriguez, Rachana Seelam, Elizabeth J D'Amic. eDirectional associations between cannabis use and depression from late adolescence through young adulthood: The role of adverse childhood experiences. Addiction (Abingdon, England). 2023-01-17. PMID:36648021. edirectional associations between cannabis use and depression from late adolescence through young adulthood: the role of adverse childhood experiences. 2023-01-17 2023-08-14 Not clear
Jordan P Davis, Eric R Pedersen, Joan S Tucker, John Prindle, Michael S Dunbar, Anthony Rodriguez, Rachana Seelam, Elizabeth J D'Amic. eDirectional associations between cannabis use and depression from late adolescence through young adulthood: The role of adverse childhood experiences. Addiction (Abingdon, England). 2023-01-17. PMID:36648021. although the co-occurrence of cannabis and depression is well-established, less is known about the temporal sequence of cannabis use and depression. 2023-01-17 2023-08-14 Not clear